<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:53:35Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9535512" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9535512</identifier>
        <datestamp>2022-10-07</datestamp>
        <setSpec>ajcn</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="reply">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Am J Clin Nutr</journal-id>
              <journal-id journal-id-type="iso-abbrev">Am J Clin Nutr</journal-id>
              <journal-id journal-id-type="publisher-id">ajcn</journal-id>
              <journal-title-group>
                <journal-title>The American Journal of Clinical Nutrition</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0002-9165</issn>
              <issn pub-type="epub">1938-3207</issn>
              <publisher>
                <publisher-name>Oxford University Press</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9535512</article-id>
              <article-id pub-id-type="pmcid">PMC9535512</article-id>
              <article-id pub-id-type="pmc-uid">9535512</article-id>
              <article-id pub-id-type="pmid">35976052</article-id>
              <article-id pub-id-type="doi">10.1093/ajcn/nqac202</article-id>
              <article-id pub-id-type="publisher-id">nqac202</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Letter to the Editor</subject>
                </subj-group>
                <subj-group subj-group-type="category-taxonomy-collection">
                  <subject>AcademicSubjects/MED00060</subject>
                  <subject>AcademicSubjects/MED00160</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Re: Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the interventional Keto-Med randomized crossover trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5803-2804</contrib-id>
                  <name>
                    <surname>Kalayjian</surname>
                    <given-names>Tro</given-names>
                  </name>
                  <aff><institution>Private practice</institution>, Tappan, NY, <country country="US">USA</country></aff>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7702-6880</contrib-id>
                  <name>
                    <surname>Westman</surname>
                    <given-names>Eric C</given-names>
                  </name>
                  <!--ewestman@duke.edu-->
                  <aff><institution>Duke University Hospital, Duke University Medical Center</institution>, Durham, NC, <country country="US">USA</country></aff>
                  <xref rid="cor1" ref-type="corresp"/>
                </contrib>
              </contrib-group>
              <author-notes>
                <corresp id="cor1">Address correspondence to ECW (e-mail: <email>ewestman@duke.edu</email>)</corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <month>10</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="epub" iso-8601-date="2022-07-26">
                <day>26</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>26</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <volume>116</volume>
              <issue>4</issue>
              <fpage>1184</fpage>
              <lpage>1184</lpage>
              <history>
                <date date-type="corrected-typeset">
                  <day>13</day>
                  <month>9</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
                </license>
              </permissions>
              <self-uri xlink:href="nqac202.pdf"/>
              <related-article related-article-type="letter" ext-link-type="doi" id="R001" xlink:href="10.1093/ajcn/nqac201"/>
              <counts>
                <page-count count="1"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <p>Dear Editor:</p>
            <p>We applaud Gardner et al. (<xref rid="bib1" ref-type="bibr">1</xref>) for their study, especially during a pandemic. Lowering dietary carbohydrate is known to improve glycemic control (<xref rid="bib2" ref-type="bibr">2</xref>), but this study has several methodological limitations, appearing as if there were a bias against the keto diet [Well Formulated Ketogenic Diet (WFKD)]. Bias #1: medication reduction was different for the 2 periods: during the WFKD period, subjects were instructed to stop the medication (which affects the main outcome of HbA1c), yet in the Mediterranean-Plus (Med-Plus) diet period, the dose was reduced by only 50% [the article states “excluding the four participants (who discontinued the medications), we observed a significant difference for both HbA1c and HDL-C between diets, favoring WFKD”]. Bias #2: changes in glycemic control “were adjusted for weight loss,” diminishing one of the advantages of the WFKD as compared with other diets: superior weight loss. Most concerning, though, are the basic design flaws that this crossover study did not have a washout period (to ensure a return to baseline state), nor a power calculation. Because a return to baseline state did not occur, most methodologists would suggest to treat the study as a parallel-group design and confine analysis to the first period alone (<xref rid="bib3" ref-type="bibr">3</xref>). So, for the primary outcome, HbA1c, we would like to see a statistical analysis confined to the first period alone for the WFKD compared with Med-Plus diets (mean change: 0.66 compared with 0.31; <italic toggle="yes">n</italic> = 16; Supplemental Table 6A). If nonsignificant, we would like to see a post hoc power calculation to assess whether sufficient subjects were included in the study to exclude a clinically meaningful difference between the 2 diets.</p>
          </body>
          <back>
            <ack id="ack1">
              <title>Acknowledgements</title>
              <p>The authors reported no funding received for this work.</p>
              <p>TK is an unpaid member of the Board of Directors of the Society of Metabolic Health Practitioners and a producer of podcasts on health and nutrition, with all proceeds donated to humanitarian charities; his spouse has ownership interest in a food company. ECW is an unpaid member of the Board of Directors of the Society of Metabolic Health Practitioners, receives royalties for the sale of diet books, and has equity in Adapt Your Life, Inc., a company based on low-carbohydrate concepts.</p>
            </ack>
            <ref-list id="ref1">
              <title>References</title>
              <ref id="bib1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gardner</surname><given-names>CD</given-names></string-name>, <string-name><surname>Landry</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Perelman</surname><given-names>D</given-names></string-name>, <string-name><surname>Petlura</surname><given-names>C</given-names></string-name>, <string-name><surname>Durand</surname><given-names>LR</given-names></string-name>, <string-name><surname>Aronica</surname><given-names>L</given-names></string-name><etal>et al.</etal></person-group><article-title>Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the interventional Keto-Med randomized crossover trial</article-title>. <source>Am J Clin Nutr</source>. <year>2022</year>; <comment>May 31</comment>(<comment>Epub ahead of print: doi: 10.1093/ajcn/nqac154</comment>).</mixed-citation>
              </ref>
              <ref id="bib2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Evert</surname><given-names>AB</given-names></string-name>, <string-name><surname>Dennison</surname><given-names>M</given-names></string-name>, <string-name><surname>Gardner</surname><given-names>CD</given-names></string-name>, <string-name><surname>Garvey</surname><given-names>WT</given-names></string-name>, <string-name><surname>Lau</surname><given-names>KHK</given-names></string-name>, <string-name><surname>MacLeod</surname><given-names>J</given-names></string-name><etal>et al.</etal></person-group><article-title>Nutrition therapy for adults with diabetes or prediabetes: a consensus report</article-title>. <source>Diabetes Care</source>. <year>2019</year>;<volume>42</volume>(<issue>5</issue>):<fpage>731</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">31000505</pub-id></mixed-citation>
              </ref>
              <ref id="bib3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sibbald</surname><given-names>B</given-names></string-name>, <string-name><surname>Roberts</surname><given-names>C</given-names></string-name></person-group>. <article-title>Understanding controlled trials. Crossover trials</article-title>. <source>BMJ</source>. <year>1998</year>;<volume>316</volume>(<issue>7146</issue>):<fpage>1719</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">9614025</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
